Eurax
NDC Package 0072-2103-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Eurax is a medication used to treat scabies. Marketed by Bristol-myers Squibb Pharma Company, this product is identified by NDC 0072-2103 and is authorized under FDA application NDA006927.

Identification & Billing

NDC Package Code
0072-2103-60
Package Description
1 TUBE in 1 CARTON / 60 g in 1 TUBE
Product Code
11-Digit Billing Format
00072210360

Clinical Specifications

Proprietary Name
Eurax
Dosage Form
-
Usage Information
This medication is used to treat scabies. Scabies is a skin infection caused by mites that burrow into the skin. Irritation from the mites leads to severe itching and small bumps/blisters filled with fluid/pus. Crotamiton works by killing the mites that cause scabies. It also helps relieve itching related to scabies and other skin conditions. Crotamiton belongs to two classes of drugs: scabicides and antipruritics.

Regulatory & Marketing

Labeler Name
Bristol-myers Squibb Pharma Company
FDA Application #
NDA006927
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-01-2009
End Marketing Date
02-28-2009
Listing Expiration
02-28-2009
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0072-2103-60 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Eurax, labeled by Bristol-myers Squibb Pharma Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bristol-myers Squibb Pharma Company on January 01, 2009. The current certification is valid through February 28, 2009.

What are the primary indications for this medication?

This medication is used to treat scabies. Scabies is a skin infection caused by mites that burrow into the skin. Irritation from the mites leads to severe itching and small bumps/blisters filled with fluid/pus. Crotamiton works by killing the mites that cause scabies. It also helps relieve itching related to scabies and other skin conditions. Crotamiton belongs to two classes of drugs: scabicides and antipruritics.

How is this Bristol-myers Squibb Pharma Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00072210360. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0072-2103-60
11-Digit CMS (5-4-2)
00072-2103-60

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.